BGM Group Ltd. (NASDAQ:BGM) Sees Significant Decrease in Short Interest

Posted by Brenda Bartman on Jul 17th, 2026

BGM Group Ltd. (NASDAQ:BGM – Get Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totaling 178,275 shares, a drop of 37.3% from the June 15th total of 284,381 shares. Approximately 0.4% of the shares of the company are short sold. Based on an average trading volume of 92,882 shares, the days-to-cover ratio is presently 1.9 days.

BGM Group Price Performance

NASDAQ:BGM traded up $0.01 on Friday, hitting $0.30. The company’s stock had a trading volume of 8,679 shares, compared to its average volume of 320,927. The stock has a fifty day moving average of $0.33 and a two-hundred day moving average of $1.14. BGM Group has a one year low of $0.26 and a one year high of $11.80.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of BGM Group in a research report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Read Our Latest Report on BGM Group

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in BGM. Geode Capital Management LLC bought a new stake in BGM Group in the 2nd quarter valued at $412,000. Mariner LLC acquired a new stake in BGM Group during the 3rd quarter valued at $267,000. Finally, Marshall Wace LLP bought a new position in BGM Group during the second quarter worth $218,000.

BGM Group Company Profile

(Get Free Report)

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.